AstraZeneca, a leading global biopharmaceutical company, in collaboration with prominent healthcare organizations, has unveiled a groundbreaking digital health platform called ‘mySihatPal.’ This initiative is poised to revolutionize access to healthcare services and information.
The esteemed healthcare societies partnering in this endeavor include Asthma Malaysia (AM), Bayi Pramatang Malaysia (BPM), Breast Cancer Welfare Association Malaysia (BCWA), Malaysian Congenital Heart Foundation (YJKM), Malaysian Endocrine & Metabolic Society (MEMS), Malaysian Family Medicine Specialists’ Association (FMSA), Persatuan SLE Malaysia (PSLEM), The Malaysian Society of Gastroenterology & Hepatology (MSGH), and the Malaysian Medical Association (MMA).
mySihatPal represents a unique and comprehensive digital health hub, offering the public direct access to a diverse spectrum of services. These services encompass vital health information, wellness resources, connections to healthcare professionals, access to private hospitals, primary care clinics, government healthcare facilities, and virtual consultations with healthcare experts and pharmacists. This transformative platform aims to ensure that everyone, regardless of their location, can achieve their highest level of health.
The global demand for healthcare advancement underscores the necessity of bridging the gap between patients and healthcare providers through digital means. Physical proximity has been a significant barrier to healthcare access, necessitating the creation of a central portal connecting individuals with healthcare experts who can provide relevant advice.
The mySihatPal portal expertly addresses this need by serving as a gateway to a vast network of medical professionals, healthcare organizations, and facilities. It also facilitates referrals to allied healthcare providers, ensuring access to comprehensive healthcare services.
Vinod Narayanan, Country President of AstraZeneca, emphasized the importance of this partnership, stating, “AstraZeneca’s mission is to collaborate with like-minded industry partners to pioneer innovative approaches, solutions, and technologies that promote equitable healthcare in Malaysia and foster digital transformation. Globally, healthcare digitalization is reshaping the delivery of healthcare services, ushering in a new era in patient care and ultimately leading to improved health outcomes.”
As a global biopharmaceutical leader, we aim to support this transformation by offering healthcare solutions that extend beyond traditional medications, catering to patient needs and nurturing innovation in digital health. The introduction of a universal digital healthcare platform like mySihatPal allows the public to access valuable resources and connect with healthcare professionals, ultimately enhancing health awareness and delivering improved patient outcomes.
added Vinod Narayanan, Country President of AstraZeneca
A distinctive feature of mySihatPal is its commitment to enhancing health literacy among users, presenting disease-related information in an understandable and user-friendly interface. Furthermore, users can conduct preliminary self-assessments of their health conditions using evaluation tools before connecting with suitable healthcare professionals through an online directory for personalized treatment.
Asthma Malaysia supports the development of a comprehensive digital health portal, providing a trustworthy platform for the public to access healthcare information and directly engage with a panel of healthcare experts. This rapid access to healthcare consultations and medications significantly reduces the time between symptom onset and medical intervention, benefiting society at large through increased healthcare awareness.
said Dr. Haji Helmy Haja Mydin, Co-Founder of Asthma Malaysia
In addition to improving healthcare accessibility, mySihatPal has plans to introduce a new user interface focusing on well-being, featuring videos and articles authored by medical professionals on various health topics.
With the myriad benefits it offers, AstraZeneca is eager to expand the network of healthcare partners on mySihatPal, inviting organizations with shared objectives to join the coalition and contribute to advancing equitable healthcare while bridging gaps in healthcare access.
The mySihatPal platform is now live and accessible to everyone at https://mysihatpal.com.my/
About AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca
dixonthum 